The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.111.7.524

The use of cardiolipin antigen especially in quantitative serologic techniques is highly satisfactory for the diagnosis and in following the course of treatment in syphilis. Persistent positive serology is not an indication for retreatment.

A positive TPI test with a negative serologic test enables one to make a retrospective diagnosis of syphilis. The exceptions to a diagnosis of "false positive" serology when the TPI is negative are the patients whose syphilis was treated in the early stage before TPI antibody could develop and a few patients with obvious late syphilis. When a chronic "false positive" serology has been identified the collagen diseases should be sought.

We still lack a technique that will indicate the survival of treponemes in the host following treatment.

Six-hundred thousand units of procaine penicillin G given daily to a total of 9 million units is the treatment of choice for neurosyphilis. This may be superseded soon by doses of benzyl amine penicillins half this size, and causing fewer side effects.

The major problem of syphilology now is the increasing difficulty of early case finding and control.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.